<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We evaluated <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e>, morbidity and mortality in patients with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We prospectively studied 70 consecutive patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e>, and 70 age- and sex-matched controls with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) but no evidence of <z:hpo ids='HP_0000112'>nephropathy</z:hpo>, from 1988 to 1998 </plain></SENT>
<SENT sid="2" pm="."><plain>Patients were evaluated at entry for <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:e sem="disease" ids="C0020473" disease_type="Disease or Syndrome" abbrv="">hyperlipidaemia</z:e>, smoking, menopause and <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> patients (64 women, 6 men) had a mean age of 35 years (SE 1.7, range 11-67) </plain></SENT>
<SENT sid="4" pm="."><plain>During the 10 years, 15 (21%) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> patients and 18 (25%) of the controls were lost to follow-up </plain></SENT>
<SENT sid="5" pm="."><plain>Compared with controls, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> patients had a higher prevalence of <z:e sem="disease" ids="C0020473" disease_type="Disease or Syndrome" abbrv="">hyperlipidaemia</z:e> (44% vs. 2%, p&lt;0.001), <z:hpo ids='HP_0000822'>hypertension</z:hpo> (44% vs. 9%, p&lt;0.001) and <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (45% vs. 22%, p=0.01) at study <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>At the last visit, 37 (67%) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> patients had <z:mpath ids='MPATH_458'>normal</z:mpath> plasma <z:chebi fb="0" ids="16737">creatinine</z:chebi>, 13 (24%) had <z:hpo ids='HP_0000083'>renal failure</z:hpo> and only five (9%) <z:hpo ids='HP_0003774'>end-stage renal failure</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0020473" disease_type="Disease or Syndrome" abbrv="">Hyperlipidaemia</z:e> (78% vs. 27%, p&lt;0.001) and <z:hpo ids='HP_0000822'>hypertension</z:hpo> (67% vs. 32%, p=0.01) at study <z:hpo ids='HP_0003674'>onset</z:hpo> were associated with development of <z:hpo ids='HP_0000083'>renal failure</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Nine <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> patients and one control died (16% vs. 2%, p=0.02) </plain></SENT>
<SENT sid="9" pm="."><plain>These patients showed more <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (56% vs. 17%, p=0.03) and <z:e sem="disease" ids="C0020473" disease_type="Disease or Syndrome" abbrv="">hyperlipidaemia</z:e> (78% vs. 37%, p=0.03) at study <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>The main causes of <z:hpo ids='HP_0011420'>death</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> patients were vascular complications (cardiovascular or cerebrovascular events) in five patients (four of whom had <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo>) and <z:hpo ids='HP_0100806'>sepsis</z:hpo> in three </plain></SENT>
</text></document>